MLYS
Price
$28.21
Change
-$0.06 (-0.21%)
Updated
Sep 4 closing price
Capitalization
2.49B
70 days until earnings call
Intraday BUY SELL Signals
MNKD
Price
$4.06
Change
+$0.10 (+2.53%)
Updated
Sep 4 closing price
Capitalization
1.31B
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLYS vs MNKD

MLYS vs MNKD Comparison Chart in %
View a ticker or compare two or three
VS
MLYS vs. MNKD commentary
Sep 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a Hold and MNKD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2026
Stock price -- (MLYS: $28.21 vs. MNKD: $4.06)
Brand notoriety: MLYS and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 85% vs. MNKD: 71%
Market capitalization -- MLYS: $2.49B vs. MNKD: $1.31B
MLYS [@Biotechnology] is valued at $2.49B. MNKD’s [@Biotechnology] market capitalization is $1.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 0 FA rating(s) are green whileMNKD’s FA Score has 1 green FA rating(s).

  • MLYS’s FA Score: 0 green, 5 red.
  • MNKD’s FA Score: 1 green, 4 red.
According to our system of comparison, both MLYS and MNKD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 5 TA indicator(s) are bullish while MNKD’s TA Score has 3 bullish TA indicator(s).

  • MLYS’s TA Score: 5 bullish, 5 bearish.
  • MNKD’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MLYS is a better buy in the short-term than MNKD.

Price Growth

MLYS (@Biotechnology) experienced а +10.20% price change this week, while MNKD (@Biotechnology) price change was +2.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.22%. For the same industry, the average monthly price growth was +5.23%, and the average quarterly price growth was +2396.59%.

Reported Earning Dates

MLYS is expected to report earnings on Nov 16, 2026.

MNKD is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-0.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLYS($2.49B) has a higher market cap than MNKD($1.31B). MLYS YTD gains are higher at: -22.265 vs. MNKD (-28.395). MNKD has higher annual earnings (EBITDA): 20.4M vs. MLYS (-370.75M). MLYS has more cash in the bank: 661M vs. MNKD (111M). MNKD has higher revenues than MLYS: MNKD (394M) vs MLYS (0).
MLYSMNKDMLYS / MNKD
Capitalization2.49B1.31B191%
EBITDA-370.75M20.4M-1,817%
Gain YTD-22.265-28.39578%
P/E RatioN/A143.00-
Revenue0394M-
Total Cash661M111M595%
Total DebtN/A331M-
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLYSMNKD
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 21 days ago
85%
Bullish Trend 21 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 11 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
77%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
MLYS
Daily Signal:
Gain/Loss:
MNKD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HOOSX33.930.06
+0.18%
Hartford Schroders US Small Cap Opps R4
VTMGX23.670.03
+0.13%
Vanguard Developed Markets Index Admiral
PARWX65.98-0.08
-0.12%
Parnassus Value Equity Investor
PZFVX23.20-0.05
-0.22%
JHancock Classic Value A
APHRX37.31-0.22
-0.59%
Artisan Global Opportunities Instl

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with IONS. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
-0.21%
IONS - MLYS
58%
Loosely correlated
-0.07%
NKTX - MLYS
37%
Loosely correlated
+4.66%
DNLI - MLYS
35%
Loosely correlated
-2.28%
TSHA - MLYS
35%
Loosely correlated
+0.54%
LXEO - MLYS
35%
Loosely correlated
+1.03%
More

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with VCYT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
+2.53%
VCYT - MNKD
44%
Loosely correlated
-4.79%
UTHR - MNKD
37%
Loosely correlated
-0.54%
AMRN - MNKD
36%
Loosely correlated
-0.58%
AXON - MNKD
35%
Loosely correlated
-4.18%
MLYS - MNKD
34%
Loosely correlated
-0.21%
More